Hippocampal neurons with staining for endosomes (turquoise and purple) and lysosomes (yellow). When the PSEN2 gene is absent or carries a familial Alzheimer-related mutation (middle), the lysosomes become noticeably enlarged.
Hippocampal neurons with staining for endosomes (turquoise and purple) and lysosomes (yellow). When the PSEN2 gene is absent or carries a familial Alzheimer-related mutation (middle), the lysosomes become noticeably enlarged.

The genetic roots of rare mutations in Alzheimer’s disease

Leuven, 3 December 2024 – Alzheimer’s disease is a debilitating condition that slowly robs people of their memory and cognitive abilities, affecting millions of people worldwide. Familial Alzheimer’s disease (FAD), a rare inherited form of the disease, is linked to mutations in several genes, including APP, PSEN1, and PSEN2. The impact of PSEN2 mutations has remained less understood—until now. A research team led by Prof. Wim Annaert at VIB-KU Leuven has shed light on how mutated PSEN2 accelerates disease progression in FAD. Their findings, published in Nature Communications, offer new insights into the mechanisms driving this genetic form of the disease.

Alzheimer’s disease is characterized by the gradual loss of cognitive function, memory, and behavioral changes, with the brain showing a build-up of amyloid plaques. These plaques form after a protein called APP (amyloid precursor protein) is “cut into pieces” by, among others, the γ-secretase complex. Some of these pieces are β-amyloid (Aβ) peptides, which can clump together to form the harmful plaques. The γ-secretase complex exists in different variants, containing either PSEN1 or PSEN2, which actually impacts its location within the cell, hinting at subtle functional differences between the two. Mutations in the genes encoding these functionally related proteins can cause FAD, an inherited form of Alzheimer’s that typically develops earlier than the more common late-onset version, with symptoms sometimes starting as early as a person's 30s or 40s.

Although it is known that toxic Aβ fragments build up early in FAD and contribute to brain damage, the specific mechanisms by which PSEN2 mutations accelerate this process were not fully understood. The lab of Prof. Wim Annaert at the VIB-KU Leuven Center for Brain & Disease Research compared the effects of a loss of PSEN2 with those of a mutant form of the PSEN2 gene to understand how disease develops in these FAD cases.

A double-edged knife

The research team studied the effects of PSEN2 loss and an FAD-linked mutation in mouse models mimicking Alzheimer’s disease. Both the absence of PSEN2 and the presence of mutated PSEN2 led to faster accumulation of amyloid plaques in the brain. Moreover, the mice with no or mutated PSEN2 ​ both exhibited significant memory impairments. These impairments correlated with structural and functional changes in the hippocampus, a key area for working memory that is primarily affected in AD patients. This brain area is essential for tasks like remembering directions while driving or walking, or following multi-step instructions, such as cooking recipes.

Consistently, the researchers observed that missing or impaired PSEN2 harmed the functioning of synapses—the connections between brain cells that allow them to communicate. The ability of synapses to strengthen over time, a process known as long-term potentiation, was impaired as well, which negatively affects learning and memory.

To uncover the origin of these impairments, the team investigated mechanisms within crucial brain cells—neurons. They found that PSEN2 plays a critical role in maintaining healthy cellular processes within late endosomes and lysosomes—the cells’ “garbage disposal system” that breaks down and recycles proteins. A lost or mutated PSEN2 gene disrupted these processes, causing a toxic build-up of APP fragments within, including Aβ peptides. So not only does impairment of the PSEN2 gene lead to more toxic amyloid plaques, it also leads to a degradative bottleneck within nerve cells, causing defects in the recycling of other molecules, including those that are responsible for transmitting signals between nerve cells.

“These results highlight the multi-faceted impact of PSEN2 mutations—on one hand, driving toxic amyloid accumulation, and on the other, impairing fundamental cellular maintenance systems, amplifying synaptic and cognitive decline”, says Anika Perdok, first author of the paper.

What this means for Alzheimer’s research

Prof. Wim Annaert emphasizes: “Our findings underscore the importance of PSEN2 in regulating brain cell health. Targeting the underlying cellular dysfunction caused by PSEN2 mutations could be a potential route for Alzheimer’s treatments. To translate these insights into treatments, we require further research, but our work suggests that therapies aimed at restoring the function of endosomes and lysosomes or normalizing γ-secretase activity in these organelles could help mitigate the effects of PSEN2 mutations and slow disease progression in FAD.”

Publication

Altered expression of Presenilin2 impacts endolysosomal homeostasis and synapse function in Alzheimer’s disease-relevant brain circuits. Perdok, et al. Nature Communications, 2024. DOI: doi.org/10.1038/s41467-024-54777-y

Funding

The research (team) was supported by the VIB, KU Leuven, the Research Foundation Flanders (FWO), Stichting Alzheimer Onderzoek - Fondation Recherche Alzheimer (STOPALZHEIMER.BE), BrightFocus, and the Alzheimer Association.


India Jane Wise

India Jane Wise

Science Communications Expert, VIB

About the VIB-KU Leuven Center for Brain & Disease Research

Scientists at the VIB-KU Leuven Center for Brain & Disease study how brain cells are organized and how they communicate with each other. These mechanisms reveal and provide insights into what goes wrong in brain diseases such as Alzheimer's, Parkinson's, ALS, and dystonia. This basic work should ultimately lead to new drugs for use against these currently incurable diseases.

 

 

Share

Latest stories

Researchers discover clues for Alzheimer’s disease in hibernation

Researchers discover clues for Alzheimer’s disease in hibernation

Leuven, 12 November 2026 – Researchers at VIB and KU Leuven have discovered that hibernation triggers changes in brain cells that partially resemble those in Alzheimer’s disease. Studying golden hamsters, the team identified changes in gene expression across the hibernation cycle, which resemble those associated with the accumulation of amyloid plaques in Alzheimer’s. The findings, published in Science Advances, suggest that some early cellular changes associated with Alzheimer’s may also occur as part of a natural adaptive response, offering new ways to study the disease for therapy development.

press.vib.be

An inside look at a molecular switch that triggers inflammation

An inside look at a molecular switch that triggers inflammation

Ghent, 9 November 2026 – Researchers at VIB and Ghent University have uncovered how an important driver of inflammation is activated at the molecular level. Their findings, published in Science Immunology, also explain how a medicine used to treat a severe form of psoriasis blocks this inflammatory signal.

press.vib.be

Researchers uncover why humans are more sensitive than other species to a brain developmental disease

Researchers uncover why humans are more sensitive than other species to a brain developmental disease

Leuven, 4 November 2026 – Researchers at VIB and KU Leuven have uncovered how mutations in the ASPM gene disrupt the development of neural stem cells that help the human brain grow. This disruption explains how these mutations cause microcephaly, a condition characterized by an abnormally small brain and head, often accompanied by intellectual disability. The discovery, published in Developmental Cell, also sheds light on how differences in brain development can make humans more susceptible to certain genetic conditions than other mammals.

press.vib.be

About VIB Press

VIB is an independent research institute that translates insights in biology into impactful innovations for society. Collaborating with the five Flemish universities, it conducts research in plant biology, cancer, neuroscience, microbiology, inflammatory diseases, artificial intelligence and more. VIB connects science with entrepreneurship and stimulates the growth of the Flemish biotech ecosystem. The institute contributes to solutions for societal challenges such as new methods for diagnostics and treatments, as well as innovations for agriculture. 

Learn more at www.vib.be.

Contact

Suzanne Tassierstraat 1 9052 Zwijnaarde

+32 9 244 66 11

press@vib.be

vib.be